Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vaccination against hepatitis B virus].

B Descos1

  • 1Gastro-entérologie infantile, Hôpital Edouard-Herriot, Lyon, France.

Pediatrie
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Hepatitis B affects over 200 million globally, necessitating effective vaccines. Recombinant hepatitis B vaccines offer a safe and potent alternative to plasma-derived vaccines, with potential for enhanced protection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Eosinophilic esophagitis. Clinical presentation, allergology and treatment: a series of 22 children].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2010
Same author

Prevention of relapse by mesalazine (Pentasa) in pediatric Crohn's disease: a multicenter, double-blind, randomized, placebo-controlled trial.

Gastroenterologie clinique et biologique·2009
Same author

Transplacental transmission of hepatitis B virus: a familial case.

The Pediatric infectious disease journal·1995
Same author

[Histiocytosis X and sclerosing cholangitis].

Annales de pediatrie·1993
Same author

[What is your diagnosis? Hemolytic-uremic syndrome].

Pediatrie·1992
Same author

[Gastric acid secretion in children with duodenal ulcer].

Archives francaises de pediatrie·1990
Same journal

[Colonic atresia: report of a case].

Pediatrie·1993
Same journal

[Psychological aspects of bone marrow donation in donor brothers and sisters in bone marrow transplantation].

Pediatrie·1993
Same journal

[Lethargy in the course of treatment with ranitidine in a newborn infant].

Pediatrie·1993
Same journal

[Delayed detection of hip dislocation: is the physician to blame?].

Pediatrie·1993
Same journal

[Renal tubular acidosis in children].

Pediatrie·1993
Same journal

[CD23: structures, functions and practical perspectives in allergy reactions].

Pediatrie·1993
See all related articles

Area of Science:

  • Hepatitis B virus (HBV) infection
  • Vaccine development
  • Immunology

Context:

  • Over 200 million people worldwide are infected with the hepatitis B virus.
  • High risk of severe liver diseases including chronic hepatitis and hepatocellular carcinoma.
  • Existing plasma-derived vaccines have demonstrated safety and efficacy, but alternative production methods are needed.

Purpose:

  • To review the development and efficacy of alternative hepatitis B vaccines.
  • To compare plasma-derived vaccines with recombinant DNA vaccines.
  • To highlight the potential benefits of pre-S2 region inclusion in mammalian recombinant vaccines.

Summary:

  • Plasma-derived hepatitis B vaccines are safe and effective but rely on carrier-derived plasma.
  • DNA recombinant vaccines, including yeast and mammalian-based, are available alternatives.

Related Experiment Videos

  • Yeast-derived recombinant vaccines show similar immunogenicity to plasma-derived vaccines.
  • Mammalian recombinant vaccines incorporating the pre-S2 region may offer faster and stronger protection.

    • Impact:

    • Provides a comprehensive overview of hepatitis B vaccine alternatives.
    • Highlights the safety, efficacy, and immunogenicity of recombinant vaccines.
    • Suggests potential for improved hepatitis B prevention strategies through advanced vaccine design.